TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pharmaxim AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
126,281
|
117,207
|
102,436 |
| Financial expenses |
644
|
615
|
280 |
| Earnings before taxes |
4,116
|
7,831
|
6,234 |
| EBITDA |
5,022
|
8,714
|
6,585 |
| Total assets |
66,613
|
60,986
|
61,228 |
| Current assets |
46,688
|
40,255
|
42,462 |
| Current liabilities |
26,719
|
19,022
|
31,837 |
| Equity capital |
29,808
|
30,140
|
27,485 |
| - share capital |
747
|
772
|
768 |
| Employees (average) |
16
|
14
|
15 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
44.7%
|
49.4%
|
44.9% |
| Turnover per employee |
7,893
|
8,372
|
6,829 |
| Profit as a percentage of turnover |
3.3%
|
6.7%
|
6.1% |
| Return on assets (ROA) |
7.1%
|
13.8%
|
10.6% |
| Current ratio |
174.7%
|
211.6%
|
133.4% |
| Return on equity (ROE) |
13.8%
|
26.0%
|
22.7% |
| Change turnover |
12,951
|
14,243
|
-19,560 |
| Change turnover % |
11%
|
14%
|
-16% |
| Chg. No. of employees |
2
|
-1
|
-1 |
| Chg. No. of employees % |
14%
|
-7%
|
-6% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.